Investigation of the Effect of Rapid Weight Loss on Anaerobic Performance, Lactic Acid, and Creatine Kinase Values in Wrestlers
1 other identifier
interventional
9
1 country
1
Brief Summary
Wrestling is a weight-classified sport in which athletes frequently apply rapid weight loss (RWL) strategies prior to competition. While the performance-related consequences of RWL have been widely investigated, its combined effects with exercise on hematological parameters and immune cell profiles remain insufficiently understood. Therefore, this study aims to examine the effects of short-term weight loss and exercise on whole blood cell parameters and lymphocyte subsets in elite wrestlers. Nine elite male wrestlers actively competing in the senior category (mean age: 22.90 ± 5.15 years; mean height: 1.75 m) voluntarily participated in this study. Athletes will achieve an average body mass reduction of 4.3% over a five-day period. Venous blood samples will be collected at 09:30 a.m. in a fasted state during two experimental phases: (1) Exercise-only phase, with blood sampling before and after exercise (BRWL1 and BRWL2); (2) Exercise plus weight loss phase, following the five-day weight loss period, with blood sampling before and after exercise (ARWL1 and ARWL2). Complete blood count parameters will be analyzed using an automated hematology analyzer, while lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, CD16/56+) will be assessed by flow cytometry. Statistical analyses will be performed with a significance level set at p \< 0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2022
CompletedFirst Submitted
Initial submission to the registry
April 22, 2026
CompletedFirst Posted
Study publicly available on registry
May 5, 2026
CompletedMay 5, 2026
April 1, 2026
10 months
April 22, 2026
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change in Leukocyte Count
Change in total white blood cell (WBC) count measured from pre- to post-exercise
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in Lymphocyte Percentage
Change in percentage of lymphocytes relative to total WBC count, measured from pre- to post-exercise.
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in CD3+ T Cell Count
Change in absolute count of CD3+ T lymphocytes measured from pre- to post-exercise.
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in CD4+ T Cell Count
Change in absolute count of CD4+ helper T lymphocytes measured from pre- to post-exercise.
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in CD8+ T Cell Count
Change in absolute count of CD8+ cytotoxic T lymphocytes measured from pre- to post-exercise.
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in CD19+ B Cell Count
Change in absolute count of CD19+ B lymphocytes measured from pre- to post-exercise.
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in CD16/56+ NK Cell Count
Change in absolute count of CD16/56+ natural killer (NK) cells measured from pre- to post-exercise.
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Secondary Outcomes (1)
Change in Creatine Kinase and Lactic Acid Levels
Pre-exercise and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Study Arms (2)
Exercise
OTHERParticipants performed a standardized wrestling exercise session on the first day of testing. Venous blood samples were collected pre- and post-exercise (pre-exercise: BRWL1; post-exercise: BRWL2) to evaluate hematological and lymphocyte subset responses.
Exercise + Rapid Weight Loss
OTHERParticipants underwent a 5-day rapid weight loss protocol prior to the exercise session, achieving an average body mass reduction of 4.3%. On the fifth day, the same standardized exercise protocol as Group 1 was performed, and pre- and post-exercise blood samples were collected (pre-exercise: ARWL1; post-exercise: ARWL2) to evaluate hematological and lymphocyte subset responses.
Interventions
Standardized wrestling exercise session; pre- and post-exercise venous blood collected
5-day rapid weight loss protocol achieving average 4.3% body mass reduction
Eligibility Criteria
You may qualify if:
- Being between 18 and 35 years of age
- Being clinically healthy
- Actively competing in wrestling
- Having regular training experience
- No history of chronic disease
- No musculoskeletal injury that could affect performance
- Not using any medication or nutritional supplements that could influence hematological or biochemical parameters during the study period
- Willing to volunteer and provide written informed consent
You may not qualify if:
- Having any chronic disease (e.g., cardiovascular, metabolic, respiratory, or neurological disorders)
- Having a recent musculoskeletal injury that could affect exercise performance
- Using medications, ergogenic aids, or nutritional supplements that might influence hematological or biochemical parameters
- Having a history of smoking or alcohol abuse
- Failing to complete the testing procedures and training protocol required for the study
- Not providing written informed consent
- Withdrawing voluntarily during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Yildirim Beyazit University Sports Sciences Laboratory
Ankara, Ankara, 06000, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2026
First Posted
May 5, 2026
Study Start
June 21, 2021
Primary Completion
April 3, 2022
Study Completion
October 10, 2022
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share